Compare Monolithic Power Systems Inc (MPWR) vs Nuvalent Inc (NUVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Monolithic Power Systems Inc vs Nuvalent Inc — how do they compare? Monolithic Power Systems Inc trades at $1,385.25 (market cap $65.28B), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: Monolithic Power Systems Inc is far larger — about 6.7× Nuvalent Inc's market cap, and Monolithic Power Systems Inc pays a 0.6% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| MPWR | NUVL | |
|---|---|---|
Market Cap | $65.28B | $9.81B |
Sector | Utilities | Technology |
52-Week High | $1.69K | $123.96 |
52-Week Low | $711.24 | $72.16 |
Enterprise Value | $63.94B | $8.52B |
Dividend Yield | 0.6% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Monolithic Power Systems Inc
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →
